We debug the human biological code — for you, for a better life. Durable, personalized immunotherapy requires understanding the precise biological signals that determine how the immune system recognizes and responds to disease. PeptideXme brings together multi-omics, structural immunology, and functional T-cell science to decode these signals and turn them into precision-guided, durable anti-tumor immunity.
Lead Scientist
I lead PeptideXme's research program in MASLD-related liver cancer, spanning basic and translational research. We employ state-of-the-art molecular approaches — (epi)genomics, transcriptomics, metabolomics, proteomics, and single-cell analysis — to interrogate the mechanisms of the immunosuppressive tumor microenvironment. Our aim is to translate molecular insight into clinical impact: identifying biologically informed strategies for improved precision oncology, and integrating multi-omic datasets with functional validation in in vivo pre-clinical models of hepatocellular carcinoma.
Liver metabolism & HCC Oncology
Epigenetic & Cancer
Molecular and Cellular Biology
Translational Hepatology
| lina.zhao@med.lu.se | |
| Phone | +46 737768101 |
| Address | Malmö, SE 214 28, Sweden |